Clinical trial

Superselective Adrenal Arterial Embolization for Resistant Hypertension

NCT05552300

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2022-10-01

PhaseNA

Study timeline

Study start (estimated)2022-10-01Date precision: day

Registry last updated2022-09-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Resistant Hypertensionunresolved

Interventions

SAAEPROCEDURE

traditional triple antihypertensive treatmentDRUG

Sponsors & collaborators

First Affiliated Hospital of Chengdu Medical Collegelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05552300 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.